IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer’s Disease Model Mice

Tiffany J. Mellott(Boston University), Jan Krzysztof Blusztajn(Boston University)

PLoS ONE

April 14, 2014

10.1371/journal.pone.0094287

Cited by 94

Related Papers

Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice

|PLoS ONE|2017|56